15-Deoxy-Δ^12,14-prostaglandin J₂ as an electrophilic mediator

References

• Smith WL. The eicosanoids and their biochemical mechanisms of action. Biochem. J. 1989;259:315–324.
   PubMed Web of Science ®Google Scholar
• Smith WL. Prostanoid biosynthesis and mechanisms of action. Am. J. Physiol. 1992;263:F181–F191.
   PubMed Web of Science ®Google Scholar
• Giles H, Leff P. The biology and pharmacology of PGD2. Prostaglandins. 1988;35:277–300.10.1016/0090-6980(88)90093-7
   PubMed Web of Science ®Google Scholar
• Urade Y, Eguchi N. Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence. Prostaglandins Other Lipid Mediat. 2002;68–69:375–382.10.1016/S0090-6980(02)00042-4
   PubMed Web of Science ®Google Scholar
• Fukushima M. Prostaglandin J2: anti-tumour and anti-viral activities and the mechanisms involved. Eicosanoids. 1990;3:189–199.
   PubMedGoogle Scholar
• Herschman HR, Reddy ST, Xie W. Function and regulation of prostaglandin synthase-2. Adv. Exp. Med. Biol. 1997;407:61–66.10.1007/978-1-4899-1813-0
   PubMed Web of Science ®Google Scholar
• Offenbacher S, Odle BM, Van Dyke TE. The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. J. Periodontal Res. 1986;21:101–112.10.1111/jre.1986.21.issue-2
   PubMed Web of Science ®Google Scholar
• Fitzpatrick FA, Wynalda MA. Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro. J. Biol. Chem. 1983;258:11713–11718.
   PubMed Web of Science ®Google Scholar
• Kikawa Y, Narumiya S, Fukushima M, Wakatsuka H, Hayaishi O. 9-Deoxy-Δ9, Δ12-13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasma. Proc. Natl. Acad. USA. 1984;81:1317–1321.10.1073/pnas.81.5.1317
   PubMed Web of Science ®Google Scholar
• Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 15-Deoxy-Δ12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell. 1995;83:803–812.10.1016/0092-8674(95)90193-0
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell. 1995;83:813–819.10.1016/0092-8674(95)90194-9
   PubMed Web of Science ®Google Scholar
• Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M, Santoro MG. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase. Nature. 2000;403:103–108.10.1038/47520
   PubMed Web of Science ®Google Scholar
• Bui T, Straus DS. Effects of cyclopentenone prostaglandins and related compounds on insulin-like growth factor-I and Waf1 gene expression. Biochim. Biophys. Acta. 1998;1397:31–42.10.1016/S0167-4781(97)00214-5
   PubMed Web of Science ®Google Scholar
• Fukushima M. Biological activities and mechanisms of action of PGJ2 and related compounds: an update. Prostaglandins Leukot. Essent. Fatty Acids. 1992;47:1–12.10.1016/0952-3278(92)90178-L
   PubMed Web of Science ®Google Scholar
• Shibata T, Kondo M, Osawa T, Shibata N, Kobayashi M, Uchida K. 15-Deoxy-Δ12,14-prostaglandin J2: a prostaglandin D2 metabolite generated during inflammatory processes. J. Biol. Chem. 2002;277:10459–10466.10.1074/jbc.M110314200
   PubMed Web of Science ®Google Scholar
• Coste A, Dubourdeau M, Linas MD, Cassaing S, Lepert JC, Balard P, Chalmeton S, Bernad J, Orfila C, Seguela JP, Pipy B. PPARγ promotes mannose receptor gene expression in murine macrophages and contributes to the induction of this receptor by il-13. Immunity. 2003;19:329–339.10.1016/S1074-7613(03)00229-2
   PubMed Web of Science ®Google Scholar
• Itoh K, Mochizuki M, Ishii Y, Ishii T, Shibata T, Kawamoto Y, Kelly V, Sekizawa K, Uchida K, Yamamoto M. Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Δ12,14-prostaglandin J2. Mol. Cell. Biol. 2004;24:36–45.10.1128/MCB.24.1.36-45.2004
   PubMed Web of Science ®Google Scholar
• Mochizuki M, Ishii Y, Itoh K, Iizuka T, Morishima Y, Kimura T, Kiwamoto T, Matsuno Y, Hegab AE, Nomura A, Sakamoto T, Uchida K, Yamamoto M, Sekizawa K. Role of 15-deoxy-Δ12,14-prostaglandin J2 and Nrf2 pathways in protection against acute lung injury. Am. J. Respir. Crit. Care Med. 2005;171:1260–1266.10.1164/rccm.200406-755OC
   PubMed Web of Science ®Google Scholar
• Kondo M, Shibata T, Kumagai T, Osawa T, Shibata N, Kobayashi M, Sasaki S, Iwata M, Noguchi N, Uchida K. 15-Deoxy-Δ12,14-prostaglandin J2: the endogenous electrophile that induces neuronal apoptosis. Proc. Natl. Acad. Sci. USA. 2002;99:7367–7372.10.1073/pnas.112212599
   PubMed Web of Science ®Google Scholar
• Sanchez-Gomez FJ, Cernuda-Morollon E, Stamatakis K, Perez-Sala D. Protein thiol modification by 15-deoxy-Δ12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes. Mol. Pharmacol. 2004;66:1349–1358.10.1124/mol.104.002824
   PubMed Web of Science ®Google Scholar
• Kim HJ, Kim JY, Meng Z, Wang LH, Liu F, Conrads TP, Burke TR, Veenstra TD, Farrar WL. 15-Deoxy-Δ12,14-prostaglandin J2 inhibits transcriptional activity of estrogen receptor-alpha via covalent modification of DNA-binding domain. Cancer Res. 2007;67:2595–2602.10.1158/0008-5472.CAN-06-3043
   PubMed Web of Science ®Google Scholar
• Shibata T, Yamada T, Ishii T, Kumazawa S, Nakamura H, Masutani H, Yodoi J, Uchida K. Thioredoxin as a molecular target of cyclopentenone prostaglandins. J. Biol. Chem. 2003;278:26046–26054.10.1074/jbc.M303690200
   PubMed Web of Science ®Google Scholar
• Shiraki T, Kamiya N, Shiki S, Kodama TS, Kakizuka A, Jingami H. Unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor γ. J. Biol. Chem. 2005;280:14145–14153.10.1074/jbc.M500901200
   PubMed Web of Science ®Google Scholar
• Shiraki T, Kodama TS, Shiki S, Nakagawa T, Jingami H. Spectroscopic analyses of the binding kinetics of 15d-PGJ2 to the PPARγ ligand-binding domain by multi-wavelength global fitting. Biochem. J. 2006;393:749–755.
   PubMed Web of Science ®Google Scholar
• Oliva JL, Perez-Sala D, Castrillo A, Martinez N, Canada FJ, Bosca L, Rojas JM. The cyclopentenone 15-deoxy-Δ12,14-prostaglandin J2 binds to and activates H-Ras. Proc. Natl. Acad. Sci. USA. 2003;100:4772–4777.10.1073/pnas.0735842100
   PubMed Web of Science ®Google Scholar
• Prestera T, Zhang Y, Spencer SR, Wilczak CA, Talalay P. The electrophile counterattack response: protection against neoplasia and toxicity. Adv. Enzyme Regul. 1993;33:281–296.10.1016/0065-2571(93)90024-8
   PubMedGoogle Scholar
• Rushmore TH, King RG, Paulson KE, Pickett CB. Regulation of glutathione S-transferase Ya subunit gene expression: identification of a unique xenobiotic-responsive element controlling inducible expression by planar aromatic compounds. Proc. Natl. Acad. Sci. USA. 1990;87:3826–3830.10.1073/pnas.87.10.3826
   PubMed Web of Science ®Google Scholar
• Friling RS, Bensimon A, Tichauer Y., Daniel V. Xenobiotic-inducible expression of murine glutathione S-transferase Ya subunit gene is controlled by an electrophile-responsive element. Proc. Natl. Acad. Sci. USA. 1990;87:6258–6262.10.1073/pnas.87.16.6258
   PubMed Web of Science ®Google Scholar
• Kawamoto Y, Nakamura Y, Naito Y, Torii Y, Kumagai T, Osawa T, Ohigashi H, Satoh K, Imagawa M, Uchida K. Cyclopentenone prostaglandins as potential inducers of phase II detoxification enzyme: 15-deoxy-Δ12,14-prostaglandin J2-induced expression of glutathione S-transferases. J. Biol. Chem. 2000;275:11291–11299.10.1074/jbc.275.15.11291
   PubMed Web of Science ®Google Scholar
• Hosoya T, Maruyama A, Kang M-I, Kawatani Y, Shibata T, Uchida K, Warabi E, Noguchi N, Itoh K, Yamamoto M. Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells. J. Biol. Chem. 2005;280:27244–27250.
   PubMed Web of Science ®Google Scholar
• Wakabayashi N, Dinkova-Kostova AT, Holtzclaw WD, Kang MI, Kobayashi A, Yamamoto M, Kensler TW, Talalay P. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc. Natl. Acad. Sci. USA. 2004;101:2040–2045.10.1073/pnas.0307301101
   PubMed Web of Science ®Google Scholar
• Kobayashi A, Kang MI, Watai Y, Tong KI, Shibata T, Uchida K, Yamamoto M. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol. Cell. Biol. 2006;26:221–229.10.1128/MCB.26.1.221-229.2006
   PubMed Web of Science ®Google Scholar
• Zhang DD, Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell. Biol. 2003;23:8137–8151.10.1128/MCB.23.22.8137-8151.2003
   PubMed Web of Science ®Google Scholar
• Eggler AL, Liu G, Pezzuto JM, van Breemen RB, Mesecar AD. Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. Proc. Natl. Acad. Sci. USA. 2005;102:10070–10075.10.1073/pnas.0502402102
   PubMed Web of Science ®Google Scholar
• Kondo M, Oya-Ito T, Kumagai T, Osawa T, Uchida K. Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress. J. Biol. Chem. 2001;276:12076–12083.10.1074/jbc.M009630200
   PubMed Web of Science ®Google Scholar
• Ishii T, Sakurai T, Usami H, Uchida K. Oxidative modification of proteasome: identification of an oxidation-sensitive subunit in 26 S proteasome. Biochemistry. 2005;44:13893–13901.10.1021/bi051336u
   PubMed Web of Science ®Google Scholar
• Ishii T, Uchida K. Induction of reversible cysteine-targeted protein oxidation by an endogenous electrophile 15-deoxy-Δ12,14-prostaglandin J2. Chem. Res. Toxicol. 2004;17:1313–1322.10.1021/tx049860+
   PubMed Web of Science ®Google Scholar
• Moos PJ, Edes K, Cassidy P, Massuda E, Fitzpatrick FA. Electrophilic prostaglandins and lipid aldehydes repress redox-sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase. J. Biol. Chem. 2003;278:745–750.10.1074/jbc.M211134200
   PubMed Web of Science ®Google Scholar
• Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell. 1994;79:13–21.10.1016/0092-8674(94)90396-4
   PubMed Web of Science ®Google Scholar
• Jentsch S, Schlenker S. Selective protein degradation: a journey's end within the proteasome. Cell. 1995;82:881–884.10.1016/0092-8674(95)90021-7
   PubMed Web of Science ®Google Scholar
• Shibata T, Yamada T, Kondo M, Tanahashi N, Tanaka K, Nakamura H, Masutani H, Yodoi J, Uchida K. An endogenous electrophile that modulates the regulatory mechanism of protein turnover: inhibitory effects of 15-deoxy-Δ12,14-prostaglandin J2 on proteasome. Biochemistry. 2003;42:13960–13968.10.1021/bi035215a
   PubMed Web of Science ®Google Scholar
• Mullally JE, Moos PJ, Edes K, Fitzpatrick FA. Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteasome pathway. J. Biol. Chem. 2001;276:30366–30373.10.1074/jbc.M102198200
   PubMed Web of Science ®Google Scholar
• Wang Z, Aris VM, Ogburn KD, Soteropoulos P, Figueiredo-Pereira ME. Prostaglandin J2 alters pro-survival and pro-death gene expression patterns and 26 S proteasome assembly in human neuroblastoma cells. J. Biol. Chem. 2006;281:21377–21386.10.1074/jbc.M601201200
   PubMed Web of Science ®Google Scholar
• Hortelano S, Castrillo A, Alvarez AM, Bosca L. Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages. J. Immunol. 2000;165:6525–6531.10.4049/jimmunol.165.11.6525
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Ono H, Mihara K, Tauchi H, Komatsu K, Shibata T, Shimizu H, Uchida K, Yamamoto K. ATM activation by a sulfhydryl-reactive inflammatory cyclopentenone prostaglandin. Genes Cells. 2006;11:779–789.10.1111/gtc.2006.11.issue-7
   PubMed Web of Science ®Google Scholar
• Kamagata C, Tsuji N, Moriai M, Kobayashi D, Watanabe N. 15-Deoxy-Δ12,14-prostaglandin J2 inhibits G2-M phase progression in human breast cancer cells via the down-regulation of cyclin B1 and survivin expression. Breast Cancer Res. Treat. 2007;102:263–273.10.1007/s10549-006-9336-3
   PubMed Web of Science ®Google Scholar
• Nakata S, Yoshida T, Shiraishi T, Horinaka M, Kouhara J, Wakada M, Sakai T. 15-Deoxy-Δ12,14-prostaglandin J2 induces death receptor 5 expression through mRNA stabilization independently of PPARγ and potentiates TRAIL-induced apoptosis. Mol. Cancer Ther. 2006;5:1827–1835.10.1158/1535-7163.MCT-06-0023
   PubMed Web of Science ®Google Scholar
• Stamatakis K, Sanchez-Gomez FJ, Perez-Sala D. Identification of novel protein targets for modification by 15-deoxy-Δ12,14-prostaglandin J2 in mesangial cells reveals multiple interactions with the cytoskeleton. J. Am. Soc. Nephrol. 2006;17:89–98.
   PubMed Web of Science ®Google Scholar
• Gayarre J, Sanchez D, Sanchez-Gomez FJ, Terron MC, Llorca O, Perez-Sala D. Addition of electrophilic lipids to actin alters filament structure. Biochem. Biophys. Res. Commun. 2006;349:1387–1393.10.1016/j.bbrc.2006.09.005
   PubMed Web of Science ®Google Scholar
• Aldini G, Carini M, Vistoli G, Shibata T, Kusano Y, Gamberoni L, Dalle-Donne I, Milzani A, Uchida K. Identification of actin as a 15-deoxy-Δ12,14-prostaglandin J2 target in neuroblastoma cells: mass spectrometric, computational and functional approaches to investigate the effect of cytoskeletal deagangement. Biochemistry. 2007;46:2707–2718.10.1021/bi0618565
   PubMed Web of Science ®Google Scholar
• Han C, Qi J, Shi X, Sakagami Y, Shibata T, Uchida K, Ojika M. Prostaglandins from a zoanthid: paclitaxel-like neurite-degenerating and microtubule-stabilizating activities. Biosci. Biotechnol. Biochem. 2006;70:706–711.10.1271/bbb.70.706
   PubMed Web of Science ®Google Scholar